Cresco Labs Inc. (CRLBF)
OTCMKTS · Delayed Price · Currency is USD
1.070
-0.090 (-7.76%)
Nov 4, 2025, 3:53 PM EST
Cresco Labs Market Cap
Cresco Labs has a market cap or net worth of $382.73 million as of November 5, 2025. Its market cap has decreased by -29.45% in one year.
Market Cap
382.73M
Enterprise Value
770.85M
Revenue
677.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.07
Market Cap Chart
Since December 3, 2018, Cresco Labs's market cap has decreased from 627.84M to 382.73M, a decrease of -39.04%. That is a compound annual growth rate of -6.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 382.73M | 19.60% |
| Dec 31, 2024 | 320.01M | -30.65% |
| Dec 29, 2023 | 461.48M | -15.53% |
| Dec 30, 2022 | 546.30M | -71.66% |
| Dec 31, 2021 | 1.93B | -17.69% |
| Dec 31, 2020 | 2.34B | 148.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 3, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 660.18M |
| Glass House Brands | 563.78M |
| Northwest Biotherapeutics | 377.06M |
| Silence Therapeutics | 338.20M |
| Nika Pharmaceuticals | 311.89M |
| American Oncology Network | 302.09M |
| CytoDyn | 297.30M |